Compare TCX & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCX | SWKH |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Diversified Financial Services |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.3M | 205.9M |
| IPO Year | 1996 | 1999 |
| Metric | TCX | SWKH |
|---|---|---|
| Price | $18.74 | $17.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 22.6K | 6.3K |
| Earning Date | 02-12-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.89 |
| EPS | N/A | ★ 1.85 |
| Revenue | ★ $390,300,000.00 | $40,149,000.00 |
| Revenue This Year | N/A | $52.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.18 |
| Revenue Growth | 7.74 | ★ 62.38 |
| 52 Week Low | $13.27 | $13.17 |
| 52 Week High | $25.17 | $20.49 |
| Indicator | TCX | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 36.40 |
| Support Level | $17.67 | $16.75 |
| Resistance Level | $20.04 | $17.49 |
| Average True Range (ATR) | 1.47 | 0.17 |
| MACD | -0.53 | -0.06 |
| Stochastic Oscillator | 16.53 | 31.03 |
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.